PFG Investments’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Buy
6,086
+53
+0.9% +$14.7K 0.05% 319
2026
Q1
$1.78M Buy
6,033
+28
+0.5% +$8.32K 0.08% 213
2025
Q4
$1.64M Buy
6,005
+2,612
+77% +$710K 0.08% 228
2025
Q3
$917K Sell
3,393
-121
-3% -$32.9K 0.05% 358
2025
Q2
$968K Buy
3,514
+267
+8% +$72.6K 0.06% 315
2025
Q1
$861K Buy
3,247
+2,032
+167% +$501K 0.06% 335
2024
Q4
$282K Sell
1,215
-29
-2% -$6.67K 0.02% 739
2024
Q3
$274K Sell
1,244
-8
-0.6% -$1.66K 0.02% 751
2024
Q2
$246K Sell
1,252
-54
-4% -$11.2K 0.02% 736
2024
Q1
$281K Buy
+1,306
New +$274K 0.02% 767

Other funds holding CME

PFG Investments's CME Position: Q2 2026 in Review

PFG Investments increased its CME Group (CME) stake by 0.88% in Q2 2026, buying an estimated $14.7K and bringing the position to 6,086 shares worth $1.34M. The position accounts for 0.05% of the portfolio, ranked #319.

PFG Investments first reported a position in CME in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.78M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • PFG Investments held 6,086 shares of CME Group worth $1.34M as of Q2 2026.
  • PFG Investments bought 53 CME Group shares in Q2 2026, an estimated $14.7K.
  • CME Group made up 0.05% of PFG Investments's portfolio in Q2 2026, its #319 holding.
  • PFG Investments first reported a position in CME Group in Q1 2024 and has held it in 10 quarters since.
  • PFG Investments's CME Group position peaked at $1.78M in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.